Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable provisions, Marksans Pharma has informed that call was held with Investors on December 21, 2021 through conference call.
The above information is a part of company’s filings submitted to BSE.